STUB1 and atherosclerosis: Clonal haematopoiesis and CHIP increase the risk for cardiovascular events, and CHIP in particular is a predictor for adverse outcomes in patients with atherosclerosis (Dregoesc et al., 2024; Gumuser et al., 2023).